Literature DB >> 6378795

Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities.

K Takayama, N Qureshi, C R Raetz, E Ribi, J Peterson, J L Cantrell, F C Pearson, J Wiggins, A G Johnson.   

Abstract

We examined the relationship between the fine structure of lipid A and the toxicity of endotoxin or lipopolysaccharides as measured by the Limulus amebocyte lysate (LAL), rabbit pyrogenicity, chicken embryo lethal dose, and dermal Shwartzman reaction tests. Lipid A and lipid A-like compounds obtained from deep-rough mutants of Salmonella spp. and Escherichia coli had a wide range of structural variations. These compounds included native lipopolysaccharides, diphosphoryl and monophosphoryl lipid A's, and lipid X (a monosaccharide). The LAL test was positive for all lipids tested with lysates from Travenol Laboratories and from Associates of Cape Cod (2.9 X 10(3) to 2.6 X 10(7) endotoxin units per mg), except for O-deacylated and dephosphorylated lipid X, which were negative. The Mallinckrodt lysate gave negative tests for lipid X. In the rabbit pyrogenicity and chicken embryo lethal dose tests, only native lipopolysaccharide and diphosphoryl lipid A's were judged toxic. The Shwartzman reaction was positive for a specific purified diphosphoryl lipid A (thin-layer chromatography-3 fraction) but negative for the purified monophosphoryl lipid A (also a thin-layer chromatography-3 fraction). These results show that the LAL test is not a valid measure of all parameters of toxicity of a lipid A or lipid A-like compound and can yield false-positive results. However, these findings are not in conflict with the widespread use of the LAL assay for pyrogens in the pharmaceutical industry since a good correlation exists between LAL results and pyrogenicity when undegraded endotoxin is evaluated in parallel assays.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378795      PMCID: PMC263228          DOI: 10.1128/iai.45.2.350-355.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  THE ROLE OF ENDOTOXIN IN THE EXTRACELLULAR COAGULATION OF LIMULUS BLOOD.

Authors:  J LEVIN; F B BANG
Journal:  Bull Johns Hopkins Hosp       Date:  1964-09

2.  Utilization of the limulus amebocyte lysate test for pyrogen testing large volume parenterals, administration sets, and medical devices.

Authors:  M Weary; B Baker
Journal:  Bull Parenter Drug Assoc       Date:  1977 May-Jun

3.  A corporate approach to in-process and end-product testing with the LAL assay for endotoxin.

Authors:  F C Pearson; M E Weary; R Dabbah
Journal:  Prog Clin Biol Res       Date:  1982

4.  FDA guideline for validation of the LAL test as an end-product endotoxin test for human and biological drugs.

Authors:  T E Munson
Journal:  Prog Clin Biol Res       Date:  1982

5.  Rapid diagnosis of gram-negative bacterial meningitis by the Limulus endotoxin assay.

Authors:  J H Jorgensen; J C Lee
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

6.  The acceptor for polar head groups of the lipid A component of Salmonella lipopolysaccharides.

Authors:  V Lehmann; J Redmond; A Egan; I Minner
Journal:  Eur J Biochem       Date:  1978-05-16

7.  Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium.

Authors:  N Qureshi; K Takayama; E Ribi
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

8.  Glucosamine-derived phospholipids in Escherichia coli. Structure and chemical modification of a triacyl glucosamine 1-phosphate found in a phosphatidylglycerol-deficient mutant.

Authors:  K Takayama; N Qureshi; P Mascagni; L Anderson; C R Raetz
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

9.  Position of ester groups in the lipid A backbone of lipopolysaccharides obtained from Salmonella typhimurium.

Authors:  N Qureshi; K Takayama; D Heller; C Fenselau
Journal:  J Biol Chem       Date:  1983-11-10       Impact factor: 5.157

10.  Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).

Authors:  D C Morrison; C G Cochrane
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  41 in total

1.  Phosphorylation of the lipid A region of meningococcal lipopolysaccharide: identification of a family of transferases that add phosphoethanolamine to lipopolysaccharide.

Authors:  Andrew D Cox; J Claire Wright; Jianjun Li; Derek W Hood; E Richard Moxon; James C Richards
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

2.  Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance.

Authors:  B E Henricson; W R Benjamin; S N Vogel
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

Review 3.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

4.  Specific detection of Haemophilus influenzae type b lipooligosaccharide by immunoassay.

Authors:  J Mertsola; R S Munford; O Ramilo; X Sáez-Llorens; M M Mustafa; G H McCracken; E J Hansen
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

5.  Incorporation of the TLR4 agonist monophosphoryl lipid A into the bilayer of DDA/TDB liposomes: physico-chemical characterization and induction of CD8+ T-cell responses in vivo.

Authors:  Pernille Nordly; Else Marie Agger; Peter Andersen; Hanne Mørck Nielsen; Camilla Foged
Journal:  Pharm Res       Date:  2010-11-02       Impact factor: 4.200

6.  Natural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-alpha in human monocytes.

Authors:  Constance M John; Mingfeng Liu; Gary A Jarvis
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

7.  Activation and inhibition of Limulus amebocyte lysate coagulation by chemically defined substructures of lipid A.

Authors:  R A Proctor; J A Textor
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

8.  Monophosphoryl lipid A induces pharmacologic 'preconditioning' in rabbit hearts without concomitant expression of 70-kDa heat shock protein.

Authors:  K Yoshida; M M Maaieh; J B Shipley; M Doloresco; N L Bernardo; Y Z Qian; G T Elliott; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1996-06-07       Impact factor: 3.396

9.  Ability of gonococcal and meningococcal lipooligosaccharides to clot Limulus amebocyte lysate.

Authors:  R I Roth; R Yamasaki; R E Mandrell; J M Griffiss
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.

Authors:  I Takahashi; S Kotani; H Takada; M Tsujimoto; T Ogawa; T Shiba; S Kusumoto; M Yamamoto; A Hasegawa; M Kiso
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.